|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 31, 2017 ) Cardiovascular disorders drug market covers the drugs used to treat conditions that affect heart or blood vessels. These conditions include heart stroke, coronary artery diseases, valvular diseases, peripheral venous diseases, pericarditis, endocarditis, cardiac tumors, arteriosclerosis, and lymphatic diseases. Some of the major cardiovascular drugs include anticoagulants such as Rivaroxaban (Xarelto), Dabigatran (Pradaxa), Apixaban (Eliquis), Heparin, and Warfarin.
For more information about this report at http://www.reportsweb.com/cardiovascular-drugs-market-global-report-2017
The global cardiovascular disorders drugs market was estimated to be around $126 billion as of 2016. The cardiovascular disorders drugs market made up around 12% of the overall pharmaceuticals market in 2016. The cardiovascular disorders drugs market was the third largest market, following the pharmaceutical drugs and biologics market in the global pharmaceutical market in 2016.
Development Of Personalized Medicine For The Treatment Of Cardiovascular Diseases
Innovation of gene testing technologies for the development of personalized medicine for cardiovascular diseases is one of the major trend in the market. Due to the reduction in the cost of gene testing, patients can screen for their predisposition for specific cardiovascular diseases. Gene testing helps in development of personalized pharmacogenomic agents and improved patient monitoring efforts and detect them before an onset of acute care episodes.
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001890199/sample
Table of Content
1. Cardiovascular Drugs Market Characteristics
2. Cardiovascular Drugs Market Size And Growth
3. Pestle Analysis
4. Cardiovascular Drugs Market Customer Information
5. Cardiovascular Drugs Market Segmentation
6. Cardiovascular Drugs Market Regional And Country Analysis
7. Global Cardiovascular Drugs Market Comparison With Macro Economic Factors
8. Cardiovascular Drugs Market Comparison With Macro Economic Factors Across Countries
9. Cardiovascular Drugs Market Comparison With Industry Metrics
10. Asia-Pacific Cardiovascular Drugs Market
11. Western Europe Cardiovascular Drugs Market
12. Eastern Europe Cardiovascular Drugs Market
13. North America Cardiovascular Drugs Market
14. South America Cardiovascular Drugs Market
15. Middle East Cardiovascular Drugs Market
16. Africa Cardiovascular Drugs Market
17. Cardiovascular Drugs Market Competitive Landscape
18. Key Mergers And Acquisitions In The Cardiovascular Drugs Market
19. Market Background: Pharmaceutical Drugs Market
20. Pharmaceuticals Industry Financial Margins
21. Appendix
Companies Mentioned
Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs)
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001890199/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
